Poster Presentations
The conference will showcase innovative approaches to fighting AMR. Scientists from companies and academic institutions were invited to submit an abstract for a poster presentation addressing the following AMR topics:
- Traditional and non-traditional therapeutic approaches to tackle AMR in humans and animals
- Technologies enabling antimicrobial vaccine and drug development (i.e. preclinical platforms, drug screening technologies, techniques for resistance testing, clinical trial design, bioinformatic tools)
- Diagnostic AMR innovations for humans and animals
- Other AMR topics relevant for drug and diagnostics development
Posters have been selected to be presented in the exhibition of the 8th AMR Conference. Among all posters, a jury will select three winners, who will be awarded a prize of 400, 600 and 1’000 Euro, respectively, kindly sponsored by Axxam. Have a look at the topics and abstracts of the chosen posters.
Bacterial Impedance Cytometry (BIC) - Gaining insights into bacterial responses to antimicrobials
Lucy Bock
UK Health Security Agency
UK Health Security Agency
Bacterial Impedance Cytometry (BIC) - Gaining insights into bacterial responses to antimicrobials
Lucy Bock
UK Health Security Agency
Read abstract
UK Health Security Agency
Microfluidic platform to visualize and quantify bacterial response to dynamic drug treatments
Friederike Born
ETH Zurich
ETH Zurich
Microfluidic platform to visualize and quantify bacterial response to dynamic drug treatments
Friederike Born
ETH Zurich
Read abstract
ETH Zurich
An anti-virulence strategy to treat Salmonella infections: Development of lead compounds targeting the transcriptional regulator HilD
Hakim Boudrioua
University Hospital Tubingen
University Hospital Tubingen
An anti-virulence strategy to treat Salmonella infections: Development of lead compounds targeting the transcriptional regulator HilD
Hakim Boudrioua
University Hospital Tubingen
Read abstract
University Hospital Tubingen
A VersaTile-driven, AI-augmented platform for the development of customized phage lysin-based antibiotics
Yves Briers
Ghent University
Ghent University
A VersaTile-driven, AI-augmented platform for the development of customized phage lysin-based antibiotics
Yves Briers
Ghent University
Read abstract
Ghent University
Phage development for clinical applications
Karine Charton
Phaxiam Therapeutics S.A.
Phaxiam Therapeutics S.A.
Mechanism of action studies using systematic analysis platform
Jan-Martin Daniel
University of Bonn
University of Bonn
Mechanism of action studies using systematic analysis platform
Jan-Martin Daniel
University of Bonn
Read abstract
University of Bonn
HoloMoA: Combination of time-lapse quantitative phase imaging with deep learning for rapidly detecting the Mechanism of Action of an antimicrobial and its potential novelty
Sophie Dixneuf
BIOASTER
BIOASTER
HoloMoA: Combination of time-lapse quantitative phase imaging with deep learning for rapidly detecting the Mechanism of Action of an antimicrobial and its potential novelty
Sophie Dixneuf
BIOASTER
Read abstract
BIOASTER
Decoding polymicrobial interactions in catheter-associated urinary tract infections
Ashim Dubey
Ecole Polytechnique Federale de Lausanne
Ecole Polytechnique Federale de Lausanne
Decoding polymicrobial interactions in catheter-associated urinary tract infections
Ashim Dubey
Ecole Polytechnique Federale de Lausanne
Read abstract
Ecole Polytechnique Federale de Lausanne
Faecal Microbiota Transplantation, a novel treatment to tackle Antimicrobial Resistance in Chronic Liver Disease …
Lindsey Edwards
King's College London
King's College London
Faecal Microbiota Transplantation, a novel treatment to tackle Antimicrobial Resistance in Chronic Liver Disease …
Lindsey Edwards
King's College London
Read abstract
King's College London
Novel AI platform for antimicrobial drug discovery
Yojana Gadiya
Fraunhofer ITMP ScreeningPort
Fraunhofer ITMP ScreeningPort
Novel AI platform for antimicrobial drug discovery
Yojana Gadiya
Fraunhofer ITMP ScreeningPort
Read abstract
Fraunhofer ITMP ScreeningPort
DCB001: a new precision antibiotic candidate against MRSA
Juan Garcia Sanchez
Université Côte d'Azur
Université Côte d'Azur
DCB001: a new precision antibiotic candidate against MRSA
Juan Garcia Sanchez
Université Côte d'Azur
Read abstract
Université Côte d'Azur
Metabolism-guided optimization of next-generation benzothiazinones towards highly potent antituberculosis agents
François Keiff & Melanie Joch
Leibniz Institute for Natural Product Research and Infection Biology
Leibniz Institute for Natural Product Research and Infection Biology
Metabolism-guided optimization of next-generation benzothiazinones towards highly potent antituberculosis agents
François Keiff & Melanie Joch
Leibniz Institute for Natural Product Research and Infection Biology
Read abstract
Leibniz Institute for Natural Product Research and Infection Biology
Inhibition and eradication of Pseudomonas aeruginosa biofilms by secondary metabolites of Nocardiopsis lucentensis EMB25
Nikky Goel
IIT Delhi
IIT Delhi
Inhibition and eradication of Pseudomonas aeruginosa biofilms by secondary metabolites of Nocardiopsis lucentensis EMB25
Nikky Goel
IIT Delhi
Read abstract
IIT Delhi
Dual mode of Action Broad-spectrum Bacterial Gyrase Inhibition by the Peptide Antibiotic Albicidin
Frank Gombert
Selmod GmbH
Selmod GmbH
Dual mode of Action Broad-spectrum Bacterial Gyrase Inhibition by the Peptide Antibiotic Albicidin
Frank Gombert
Selmod GmbH
Read abstract
Selmod GmbH
Disperazol: treating Pseudomonas aeruginosa catheter associated urinary tract biofilm infections
Michael Graz
Biophys Ltd.
Biophys Ltd.
Disperazol: treating Pseudomonas aeruginosa catheter associated urinary tract biofilm infections
Michael Graz
Biophys Ltd.
Read abstract
Biophys Ltd.
Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infection
Mai Hoang
Dynamic42 GmbH
Dynamic42 GmbH
Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infection
Mai Hoang
Dynamic42 GmbH
Read abstract
Dynamic42 GmbH
SimCells: genome-free bacterial cells as vaccines against Pseudomonas aeruginosa infections
Jane Hsu
Oxford SimCell Ltd.
Oxford SimCell Ltd.
SimCells: genome-free bacterial cells as vaccines against Pseudomonas aeruginosa infections
Jane Hsu
Oxford SimCell Ltd.
Read abstract
Oxford SimCell Ltd.
Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity
Tim Kaden
Dynamic42 GmbH
Dynamic42 GmbH
Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity
Tim Kaden
Dynamic42 GmbH
Read abstract
Dynamic42 GmbH
Utilising optical electrophysiology for rapid antimicrobial susceptibility testing to enhance bloodstream infections and sepsis management
Magdalena Karlikowska
Cytecom Ltd.
Cytecom Ltd.
Utilising optical electrophysiology for rapid antimicrobial susceptibility testing to enhance bloodstream infections and sepsis management
Magdalena Karlikowska
Cytecom Ltd.
Read abstract
Cytecom Ltd.
The COMBINE Preclinical Bacterial Strain Repository - A new resource for preclinical lung infection models to assess antibiotic efficacy
Bernhard Kerscher
Paul Ehrlich Institute
Paul Ehrlich Institute
The COMBINE Preclinical Bacterial Strain Repository - A new resource for preclinical lung infection models to assess antibiotic efficacy
Bernhard Kerscher
Paul Ehrlich Institute
Read abstract
Paul Ehrlich Institute
New rapid detection of beta-lactamase producing bacteria using fluorogenic probes
Anne Khoschnud
Molsid S.A.S.
Molsid S.A.S.
New rapid detection of beta-lactamase producing bacteria using fluorogenic probes
Anne Khoschnud
Molsid S.A.S.
Read abstract
Molsid S.A.S.
Intracellular growth and persistence of Pseudomonas aeruginosa in a lung tissue model
Luisa Lauer
University of Basel
University of Basel
Intracellular growth and persistence of Pseudomonas aeruginosa in a lung tissue model
Luisa Lauer
University of Basel
Read abstract
University of Basel
Paride - a new Pseudomonas aeruginosa phage
Enea Maffei
ETH Zurich
ETH Zurich
Identification of new antimicrobial resistance genes in E. coli through network diffusion
Anis Mansouri
University of Bologna
University of Bologna
Identification of new antimicrobial resistance genes in E. coli through network diffusion
Anis Mansouri
University of Bologna
Read abstract
University of Bologna
Empowering Antibiotics in the AMR Landscape: Insights from Dendrimer Conjugation in ALI systems
Laura Martinenghi
Copenhagen University
Copenhagen University
Empowering Antibiotics in the AMR Landscape: Insights from Dendrimer Conjugation in ALI systems
Laura Martinenghi
Copenhagen University
Read abstract
Copenhagen University
The DSMZ bacteriophage collection and its relevance for fighting antimicrobial resistance
Filipa Martins
DSMZ - German Collection of Microorganisms and Cell Cultures
DSMZ - German Collection of Microorganisms and Cell Cultures
The DSMZ bacteriophage collection and its relevance for fighting antimicrobial resistance
Filipa Martins
DSMZ - German Collection of Microorganisms and Cell Cultures
Read abstract
DSMZ - German Collection of Microorganisms and Cell Cultures
An MD simulation-enhanced machine learning virtual screening for permeability and accumulation of antimicrobials
Stefan Milenkovic
University of Cagliari
University of Cagliari
An MD simulation-enhanced machine learning virtual screening for permeability and accumulation of antimicrobials
Stefan Milenkovic
University of Cagliari
Read abstract
University of Cagliari
Facilitating Phage Applications in Africa and Asia
Tobi Nagel
Phages for Global Health
Phages for Global Health
Dimercaptosuccinic acid in combination with carbapenems against strains of Pseudomonas aeruginosa and Acinetobacter baumannii producing metallo-ß-lactamase in a murine peritonitis model
Patrice Nordmann
Université de Fribourg
Université de Fribourg
Dimercaptosuccinic acid in combination with carbapenems against strains of Pseudomonas aeruginosa and Acinetobacter baumannii producing metallo-ß-lactamase in a murine peritonitis model
Patrice Nordmann
Université de Fribourg
Read abstract
Université de Fribourg
Novel antibiotic peptides in the fight against AMR
Marit Otterlei
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Novel antibiotic peptides in the fight against AMR
Marit Otterlei
Norwegian University of Science and Technology
Read abstract
Norwegian University of Science and Technology
Proteomics: Revolution in bacteria identification and AMR detection in one
Armand Paauw
Netherlands Organization for Applied Scientific Research TNO
Netherlands Organization for Applied Scientific Research TNO
Proteomics: Revolution in bacteria identification and AMR detection in one
Armand Paauw
Netherlands Organization for Applied Scientific Research TNO
Read abstract
Netherlands Organization for Applied Scientific Research TNO
Human bladder microtissue model to study chronic and recurrent UTIs
Gauri Paduthol
Ecole Polytechnique Federale de Lausanne
Ecole Polytechnique Federale de Lausanne
Human bladder microtissue model to study chronic and recurrent UTIs
Gauri Paduthol
Ecole Polytechnique Federale de Lausanne
Read abstract
Ecole Polytechnique Federale de Lausanne
Human monoclonal antibodies targeting novel, fungal cell wall proteins offer superior therapeutic efficacy in a preclinical model of infection
Soumya Palliyil
University of Aberdeen
University of Aberdeen
Human monoclonal antibodies targeting novel, fungal cell wall proteins offer superior therapeutic efficacy in a preclinical model of infection
Soumya Palliyil
University of Aberdeen
Read abstract
University of Aberdeen
Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)
Elliott Pauli
RTI International
RTI International
Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)
Elliott Pauli
RTI International
Read abstract
RTI International
How GARDP’s REVIVE platform is providing open-access tools and resources for the antimicrobial R&D community
Astrid Pentz-Murr
GARDP
GARDP
How GARDP’s REVIVE platform is providing open-access tools and resources for the antimicrobial R&D community
Astrid Pentz-Murr
GARDP
Read abstract
GARDP
The human microbiome as source and target for new antibacterial compounds
Andreas Peschel
University of Tubingen
University of Tubingen
The human microbiome as source and target for new antibacterial compounds
Andreas Peschel
University of Tubingen
Read abstract
University of Tubingen
The Swiss Round Table on Antibiotics fosters the development and availability of antibiotics
Barbara Polek
Round Table on Antibiotics
Round Table on Antibiotics
The Swiss Round Table on Antibiotics fosters the development and availability of antibiotics
Barbara Polek
Round Table on Antibiotics
Read abstract
Round Table on Antibiotics
Use of Sub-Cellular Fluctuation Imaging (SCFI) for real-time monitoring of antibiotic resistance in N. gonorrhoeae
James Preece
FluoretiQ Ltd.
FluoretiQ Ltd.
Use of Sub-Cellular Fluctuation Imaging (SCFI) for real-time monitoring of antibiotic resistance in N. gonorrhoeae
James Preece
FluoretiQ Ltd.
Read abstract
FluoretiQ Ltd.
VERI-5.: a compact hardware and single use cartridge system for rapid detection of Urinary Tract Infections
James Preece
FluoretiQ Ltd.
FluoretiQ Ltd.
VERI-5.: a compact hardware and single use cartridge system for rapid detection of Urinary Tract Infections
James Preece
FluoretiQ Ltd.
Read abstract
FluoretiQ Ltd.
Self-adjuvant nanovaccination as novel tool to combat bacterial infections
Oliver Reimann
Belyntic GmbH
Belyntic GmbH
Self-adjuvant nanovaccination as novel tool to combat bacterial infections
Oliver Reimann
Belyntic GmbH
Read abstract
Belyntic GmbH
Highly-neutralizing anti-PcrV antibodies as clinical candidates against Pseudomonas aeruginosa
Jan Rybniker
Center for Molecular Medicine Cologne
Center for Molecular Medicine Cologne
Highly-neutralizing anti-PcrV antibodies as clinical candidates against Pseudomonas aeruginosa
Jan Rybniker
Center for Molecular Medicine Cologne
Read abstract
Center for Molecular Medicine Cologne
Turning enzymes into efficient enzybiotics
Izabela Sabala
Mossakowski Medical Research Institute PAS
Mossakowski Medical Research Institute PAS
Turning enzymes into efficient enzybiotics
Izabela Sabala
Mossakowski Medical Research Institute PAS
Read abstract
Mossakowski Medical Research Institute PAS
Microbialbiosensor for industrial online analysis
Tobias Schröter
FluIDect GmbH
FluIDect GmbH
Development of a Synthetic Human Urine formulation for the study of uropathogenic E. coli (UPEC) physiology and the discovery of antibiotics
Benjamin Sellner
University of Basel
University of Basel
Development of a Synthetic Human Urine formulation for the study of uropathogenic E. coli (UPEC) physiology and the discovery of antibiotics
Benjamin Sellner
University of Basel
Read abstract
University of Basel
Retrospective analysis of cefiderocol for treating severe drug- resistant gram negative bacterial infections
Leeanne Stewart
Belfast Health and Social Care Trust
Belfast Health and Social Care Trust
Retrospective analysis of cefiderocol for treating severe drug- resistant gram negative bacterial infections
Leeanne Stewart
Belfast Health and Social Care Trust
Read abstract
Belfast Health and Social Care Trust
Exploring Challenges in Vaccine Development for Emerging Pathogens: A Study of Regulatory Interactions between Developers and Regulators
Igor Stojkov
Paul Ehrlich Institute
Paul Ehrlich Institute
Exploring Challenges in Vaccine Development for Emerging Pathogens: A Study of Regulatory Interactions between Developers and Regulators
Igor Stojkov
Paul Ehrlich Institute
Read abstract
Paul Ehrlich Institute
New Generation Antimicrobials Developed Using Efflux Resistance Breaker (ERB) Technology
Mark Sutton
UK Health Security Agency
UK Health Security Agency
New Generation Antimicrobials Developed Using Efflux Resistance Breaker (ERB) Technology
Mark Sutton
UK Health Security Agency
Read abstract
UK Health Security Agency
An in vivo-like lung infection model for pharmacokinetics and -dynamics studies
Leoni Swart
University of Basel
University of Basel
An in vivo-like lung infection model for pharmacokinetics and -dynamics studies
Leoni Swart
University of Basel
Read abstract
University of Basel
MptpB inhibitors increase the efficacy of antibiotics reducing intracellular burden for Mycobacterium tuberculosis and nontuberculous Mycobacterium avium
Lydia Tabernero
University of Manchester
University of Manchester
MptpB inhibitors increase the efficacy of antibiotics reducing intracellular burden for Mycobacterium tuberculosis and nontuberculous Mycobacterium avium
Lydia Tabernero
University of Manchester
Read abstract
University of Manchester
Search for the new generation of the antifungal drugs based on the polyene antibiotics
Anna Tevyashova
Constructor University
Constructor University
Search for the new generation of the antifungal drugs based on the polyene antibiotics
Anna Tevyashova
Constructor University
Read abstract
Constructor University
Human urothelial microtissue model for in vitro studies of urinary tract infection and its treatment
Lisette van Os
University of Basel
University of Basel
Human urothelial microtissue model for in vitro studies of urinary tract infection and its treatment
Lisette van Os
University of Basel
Read abstract
University of Basel
New bioluminescent preclinical infection mouse models using recently isolated strain of multi drug resistant KAPE bacteria
Marc Vandamme
Voxcan
Voxcan
New bioluminescent preclinical infection mouse models using recently isolated strain of multi drug resistant KAPE bacteria
Marc Vandamme
Voxcan
Read abstract
Voxcan
Next Generation Assay Optimisation for Drug Screening Using design of experiments and automation for antibiotic adjuvant discovery
Adam Winnifrith
University of Oxford
University of Oxford
Next Generation Assay Optimisation for Drug Screening Using design of experiments and automation for antibiotic adjuvant discovery
Adam Winnifrith
University of Oxford
Read abstract
University of Oxford
Acceleration of Hit-to-Lead Drug Development by Nanoliter-scale Screening of Mutasynthetic BamA Inhibitor Library
Zerlina Wuisan
University of Giessen
University of Giessen
Acceleration of Hit-to-Lead Drug Development by Nanoliter-scale Screening of Mutasynthetic BamA Inhibitor Library
Zerlina Wuisan
University of Giessen
Read abstract
University of Giessen
BTZ-043 shows good safety and strong bactericidal activity in a seamless phase 1b/2a study in patients with pulmonary TB
Julia Dreisbach
University Hospital Munich
University Hospital Munich
BTZ-043 shows good safety and strong bactericidal activity in a seamless phase 1b/2a study in patients with pulmonary TB
Julia Dreisbach
University Hospital Munich
Read abstract
University Hospital Munich
Granulytics: Antimicrobial protein-lipid complexes derived from the human immune peptides to tackle Antimicrobial resistance
Owais Hameed
Université de Fribourg
Université de Fribourg
Granulytics: Antimicrobial protein-lipid complexes derived from the human immune peptides to tackle Antimicrobial resistance
Owais Hameed
Université de Fribourg
Read abstract
Université de Fribourg
High‐throughput sequencing technologies for genome methylation analysis and possible epigenetic intervention strategies in the model bacterium Helicobacter pylori
Christine Josenhans
Ludwig Maximilian University Munich
Ludwig Maximilian University Munich
High‐throughput sequencing technologies for genome methylation analysis and possible epigenetic intervention strategies in the model bacterium Helicobacter pylori
Christine Josenhans
Ludwig Maximilian University Munich
Read abstract
Ludwig Maximilian University Munich
Novel thiopeptides to target intractable bacterial infections
Clovis Shyaka
A&J Science
A&J Science
Novel thiopeptides to target intractable bacterial infections
Clovis Shyaka
A&J Science
Read abstract
A&J Science
From Stress to Adaptive Success: A systematic investigation of physiological adaptation of Escherichia coli facing harsh environments
Alexandra Evelyne Huber
University of Basel
University of Basel
From Stress to Adaptive Success: A systematic investigation of physiological adaptation of Escherichia coli facing harsh environments
Alexandra Evelyne Huber
University of Basel
Read abstract
University of Basel
Combining growth inhibition assays and metabolic profiling to accelerate discovery of antibiotics with unconventional modes of action
Sebastián Sosa-Carrillo
University of Basel
University of Basel
Combining growth inhibition assays and metabolic profiling to accelerate discovery of antibiotics with unconventional modes of action
Sebastián Sosa-Carrillo
University of Basel
Read abstract
University of Basel